Literature DB >> 17548459

Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.

Daniel Curcio, Francisco Fernández, Ronald N Jones, Mary Jane Ferraro, L Barth Reller, Paul C Schreckenberger, Helio S Sader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17548459      PMCID： PMC1933103          DOI： 10.1128/JCM.00107-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  5 in total

Review 1.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Authors:  Jian Li; Roger L Nation; John D Turnidge; Robert W Milne; Kingsley Coulthard; Craig R Rayner; David L Paterson
Journal:  Lancet Infect Dis       Date:  2006-09       Impact factor: 25.071

2.  Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the Americas.

Authors:  Fernando Pasterán; Melina Rapoport; Alejandro Petroni; Diego Faccone; Alejandra Corso; Marcelo Galas; Miryam Vázquez; Adriana Procopio; Marta Tokumoto; Viviana Cagnoni
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

Review 3.  Tigecycline.

Authors:  George A Pankey
Journal:  J Antimicrob Chemother       Date:  2005-07-22       Impact factor: 5.790

4.  Appropriateness and delay to initiate therapy in ventilator-associated pneumonia.

Authors:  C M Luna; P Aruj; M S Niederman; J Garzón; D Violi; A Prignoni; F Ríos; S Baquero; S Gando
Journal:  Eur Respir J       Date:  2006-01       Impact factor: 16.671

5.  Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.

Authors:  Ronald N Jones; Mary Jane Ferraro; L Barth Reller; Paul C Schreckenberger; Jana M Swenson; Helio S Sader
Journal:  J Clin Microbiol       Date:  2006-11-08       Impact factor: 5.948
  5 in total
  2 in total

Review 1.  Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence.

Authors:  Drosos E Karageorgopoulos; Theodore Kelesidis; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-04-24       Impact factor: 5.790

2.  In Vitro Activity of Tigecycline and Colistin against clinical isolates of Acinetobacter baumannii in Hospitals in Tehran and Bandar-Abbas, Iran.

Authors:  Shahin Najar Peerayeh; Afsaneh Karmostaji; Soraya Sharifi Sarasiabi; Sedigheh Javadpour; Parivash Davoodian; Nahid Moradi
Journal:  Electron Physician       Date:  2014-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.